Member Info for jdt1990

Exactly - That's the key part you highlighted there PL. Using AN as a sample method means people are much more likely in real world settings to obtain a useful sample properly. Meaning there is less likely to be a divergence between lab / clinical validation and real world S&S.
Brain tickler was a problem because nobody wanted to tickle their brain with a swab.....it was so open to error.
So to recreate the top end S&S using AN is pretty damn good!

Not really - that assumes you have free cash to invest. If you have a holding you are comfortable with but no funds to top up - doing nothing is perfectly sensible.

Oh Mars1 - you've just got this ohhhh soooo wrong. Antibody testing has no place in hospitality reopening. Vaccinated people can still catch, carry and transmit the virus. Which therefore means you need a test to find who is infectious at that point in time to (regardless of vaccine or no vaccine). Not a test to show you have antibodies that simply reduce the effects of the virus on the infected person.
Antibody testing will be key to research on vaccine effectiveness.

"Our big brother is now in complete control of what happens here"
Utter garbage....
"So if they are slowly acquiring we are in trouble."
You would see a series of TR1s if a significant stake was being built to facilitate a hostile takeover and, any takeover bid has to be approved by shareholders which at this point is very very clear it would be rejected!

Sliotar "My worry is that we are now getting to a level where we can be taken out at a far lower level than where we were a mere 6 weeks ago"
Any takeover bid would have to be approved by shareholders. Anything at this level would almost certainly be rejected! Unless someone build up a large enough shareholding....but in that case we would have a TR1 and know who is building a stake

Becky! GDXJ only buy and sell between rebalances to fund subscriptions/redemptions in the ETF. That is done proportionately across all holdings.
GDXJ AUM is fairly steady - it isnt them

If you buy directly there are no capital calls, only if you are trading on swap/spreadbet/CFD/options

Ridiculous comment Freddie. Nothing has changed since the man took on the role.
His job isn't to fight short term market moves, it's to build a fundamentally string business.
He knows what is there with HAV and the potential of all the other tenements -if anyone is going to NOT be worries its Shaun Day

It's not for SD to just buy some shares to keep investors "reassured". His job is to build a fundamentally strong business that the market has to price appropriately.

KB007 - the LSE shares in issue number for KAN looks wrong.
As tutter said 15,000,000p/6.5p = 2,307,692 shares.
https://www.londonstockexchange.com/news-article/KNB/admission-and-first-day-of-dealings/14866016
Lond Stock Exchg RNS states:
"on Admission the Company will have 360,229,328 ordinary shares of 2.5p each in issue, each share carrying the right to one vote."
so 2,307,692 / 360,229,328 = ~0.6%

Not sure the KIBO move really impacts KAT holders (unless of course you are directly invested in both). KAT move when news flow starts will help KIBO SP but KAT need a Blyvoor update which is currently 10 months late from initial timeline and hopefully some goo Haneti results!

A very good summary from BBN of just what today likely means in terms of the potential govt tie up. When you look at what AVCT have produced at those Ct levels using AN sample method, Versus Innova's nasopharyngeal method is pretty remarkable.
If this stays in that S&S range in a larger sample size, it's impossible to see how having spent billions on s*itty Innova tests, they would not want everything AS could produce!
Looks like AS has set this up nicely though to leave some capacity for the private market where margin will no doubt be larger.

https://twitter.com/BigBiteNow/status/1361590848715173889

Abbey - Just take a step back and think how this works. VELA invest £150,000 in a company and make £300k "profit" which is actually just a paper gain.
£300k is about 2.5% of overall market cap so it's hardly going to move the dial.....this is essentially a VC firm making various investments in the hope of getting into good companies early to reap LONG TERM rewards as they develop.
The SP here will take time to mature on fundamentals. There will be plenty of volatility on people trading this.
It wont just magically mirror the rise of KAN.

Or just some news on Blyvoor - getting beyond a joke now! They had the draft SAMVAls 18Dec which were required for the "interested parties" to progress. Over 8 week slater.....zilch

This is very much just the start here! $106m NPV for current resource estimate V £25m mkt cap and
"Further upside is expected through the delineation of expanded total resources to be calculated upon conclusion of ongoing drilling programme"

Crickey some really don’t do any research in their investments do they!

In other news - this should keep Melissa quiet for a while. Shows why JN is in charge and not her!

Still at it NDN - FFS no pleasing some!!!

Agreed there's a lot on here who should just suck it up and apologise for their constant berating of AS timelines "wheres my test? Is it ready yet?". Well, If its worth doing, its worth doing properly, otherwise Innova was the investment for you!

A humbling post Rebecca. Sorry to hear about your loss, such awful news. I am glad Avct could provide you with something positive this morning.

Hahahahahah another ODX pleb - nice try MrBigdeal.
Going to be a lot of these idiots today.
AMAZING NEWS! Well done all that have held here through thick and thin, ups and downs and defended this share to the hilt and it turns out rightly so!
If it’s worth doing, it’s worth doing properly.
Sir Al - I knew you had it in you all along!